Androgen deprivation therapy (ADT), androgen receptor (AR) pathway inhibitors (ARPi), and chemotherapy are standard treatments for locally advanced or metastatic prostate cancer (3). The gene discussed is AR; the disease is metastatic prostate carcinoma.